Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy

Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy

Nobuki Furubayashi,1 Takahito Negishi,1 Naotaka Sakamoto,2 Hozumi Shimokawa,3 Futoshi Morokuma,4 Yoohyun Song,5 Yoshifumi Hori,6 Toshihisa Tomoda,7 Noriaki Tokuda,4 Narihito Seki,5 Kentaro Kuroiwa,6 Motonobu Nakamura1 1Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuo...

Full description

Bibliographic Details
Main Authors: Furubayashi N, Negishi T, Sakamoto N, Shimokawa H, Morokuma F, Song Y, Hori Y, Tomoda T, Tokuda N, Seki N, Kuroiwa K, Nakamura M
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:OncoTargets and Therapy
Subjects:
urothelial carcinoma
platinum-based chemotherapy
pembrolizumab
organ-specific response rate
tumor microenvironment
Online Access:https://www.dovepress.com/organ-specific-tumor-response-to-pembrolizumab-in-advanced-urothelial--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/organ-specific-tumor-response-to-pembrolizumab-in-advanced-urothelial--peer-reviewed-article-OTT

Similar Items